Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilnidipine + valsartan versus valsartan alone in inadequately controlled hypertension
KCT0001947Phase 3Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cilnidipine and valsartan in hypertension (HTN) (3 arms), sponsored by Ildong Pharmaceutical Co Ltd. Started Jul 2014; status: completed.
02
Drugs
cilnidipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on KCT0001947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001947.